Cadila Pharmaceuticals Limited
FDA inspection history in Ankleshwar, India, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Ankleshwar, India.
Cited most
Across all Cadila Pharmaceuticals Limited observations on file
- 21 CFR 211.165Testing and release for distribution1
The complete Cadila Pharmaceuticals Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ankleshwar, India
One Form 483 · 2023 · 1 observation
Latest: Form 483, Jan 20, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-01-20 | 483 Form 483 | Ankleshwar, India | 1 | $99 |
FEI number 3014078015 · most recent document Jan 20, 2023
About Cadila Pharmaceuticals Limited
How many FDA Form 483s has Cadila Pharmaceuticals Limited received?
FDA Intel has 1 Form 483 on file for Cadila Pharmaceuticals Limited; the most recent is dated Jan 20, 2023.
When was Cadila Pharmaceuticals Limited last inspected by FDA?
The most recent FDA inspection document on file for Cadila Pharmaceuticals Limited is a Form 483 dated Jan 20, 2023, for the site in Ankleshwar, India.
What did FDA cite at Cadila Pharmaceuticals Limited?
The regulations cited most in the observations on file for Cadila Pharmaceuticals Limited are 21 CFR 211.165 (Testing and release for distribution), 1 time.